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The immune system is a complex and interactive network of specialized 
cells, lymphoid organs, circulating humoral factors and cytokines. Its main 
function is to recognize pathogens and subsequently organize and execute a 
proper response. While it attacks microbial threats, it also avoids damaging 
neighboring host cells through a phenomenon known as to self-tolerance. 
The immune system is also a crucial element in the maintenance of homeo-
stasis because it allows organisms to control an internal environment of the 
self, while allowing an important interacting connection with the external 
environment. The importance of the immune system in our health can be 
better appreciated under abnormal conditions, i.e. when it is not able to 
recognize and attack pathogens or distinguish a pathogen threat from itself. 
Suboptimal recognition and response can lead to immunodeficiencies and 
susceptibility to infectious diseases, whereas an overactive immune system 
can lead to autoimmunity, allergies and, consequently, to tissue damage. 
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General introduction and aim and outline of thesis.
An appropriate and timely immune response to an external or internal 
threat is the primary functional characteristic of the immune system. Based 
on the specificity and timing of the response, it can be classified into two 
distinct types. The innate response, commonly known as the first line of 
defense against external microbes, includes physical and chemical barri-
ers that evolved to decrease the chances of being infected by a dangerous 
pathogen. Based on its biological components, this type of response groups 
myeloid cells, the complement cascade and cytokines that are able to gen-
erate an almost instant reaction to a recognized external threat. However, 
this short response time comes at a price: the innate response is not very 
specific, does not have memory and can potentially lead to tissue damage 
and uncontrolled inflammation. The importance of the innate response to 
survival can also be seen evolutionarily, as most of the cytokines and tran-
scription factors involved in innate response have multiple functions and are 
highly conserved across the animal kingdom. In contrast, the second type of 
response – adaptive response – is the coordinated response of T and B cells 
through antigen-specific reactions. This response, although highly specific, 
can be quite slow. It can take the host multiple days or weeks to develop it. 
Nevertheless, due to the specificity in the antigen reactions, the adaptive 
response can specifically target recognized pathogens, thereby avoiding al-
most any damage to neighboring tissues. The adaptive response can also 
develop memory. Once a pathogen has been in contact with the host, the 
host’s adaptive system will remember its previous encounter, leading to a 
faster secondary response in the future. 
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Humans, like other higher animals, possess an innate and adaptive 
immune response, each of them recruiting several cell types and signaling 
molecules. Many of these cell types are highly conserved across genera and 
species, highlighting the importance of the immune system to survival. Re-
cent studies aimed at characterizing key regulatory factors using popula-
tion-based cohorts have observed that there is a considerable range of vari-
ation between individuals in the composition and response of the multiple 
cell types, cytokines and molecules that compose the immune system (Li 
et al. 2016; Brodin et al. 2015; Orrù et al. 2013; Roederer et al. 2015). This 
inter-individual variation is, in itself, an essential component of our eternal 
conflict with pathogens. Variability between us increases our chances of sur-
Figure 1. Inter-individual variation of the human immune system. The variation in re-
sponse to threat in the general population is still not fully characterized. However, through 
the use of population-based cohorts, we have been able to dissect the genetic component of 
the inter-individual variation of the immune system. These results suggest that the observed 
range of inter-individual variation of the immune response is mostly the result of interaction 
between genetics and environmental factors that defines a baseline immune composition 
and response. This gene-environment interaction generates a diverging gradient of immune 
response in the general population. The majority of the individuals show a homeostatic im-
mune response that involves proper tissue- and cell-type-development, microbiome symbi-
osis, regulation of metabolism, adequate response to infections, wound healing and tissue 
repair. However, on the extremes of the diverging gradient of immune response, we observe 
the emergence of disease-like phenotypes, such as autoimmune diseases, and susceptibility 
to infectious agents.
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vival in pandemic-like scenarios by ensuring a diversified response to any 
given pathogen. Nevertheless, inter-individual variation can lead, in some 
cases, to extreme disease-like phenotypes. As illustrated in Fig. 1, we now 
know that the variation in the immune response arises through interactions 
across three main components: (1) genetics, (2) environment/lifestyle and 
(3) host molecular and immune composition. Therefore, by having a specific 
genetic makeup or by being exposed to certain environmental triggers, a 
person could develop extreme and diverging immune responses. To one 
end of the spectrum the immune system could become overactive, giving 
rise to autoimmune disorders and chronic inflammatory conditions. On the 
other end of the spectrum, immunodeficiencies and greater susceptibility to 
pathogens are more likely to arise in an individual with a genetic predispo-
sition that causes an underactive immune system. Therefore, by character-
izing and understanding the key genetic or environmental factors that are 
actively regulating and driving the inter-individual variation of the human 
immune system and response, we can potentially predict and prevent ex-
treme and disease-like immune phenotypes. 
Fully understanding the complex network of signals behind our immune sys-
tem in a holistic way requires a systematic quantification of its components. 
Recent technological advances in high-throughput biology have made it pos-
sible to quantify a wide range of features involved in the immune system/
response. These immune-related features are also known as immunophe-
notypes, or immune traits. Immunophenotypes can be characterized into 
two main groups defined by the level of biological information they encode: 
they can be cellular or molecular. 
A cellular immunophenotype refers to the quantification of cellular com-
ponents of the immune system, including cell type counts/frequencies, cell 
proliferation rates, serum protein levels and surface and signaling markers. 
Initially, studies investigating cellular immunophenotypes were focused on 
quantifying a handful of them, such as cell proportions of major categories 
of circulating immune subpopulations (e.g. neutrophils, lymphocytes and 
monocytes). However, flow and mass cytometry (CyTOFF) are now common-
ly used and these techniques allow us to characterize hundreds of features 
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in hundreds to thousands of samples. 
Molecular immunophenotypes encompass transcriptional and epigenetic 
markers such as methylation and chromatin mark profiles, in addition to 
protein levels from either purified of immune cell subpopulations or mix-
tures of them (PBMCs or whole blood). At present, multiple studies are being 
carried out to systematically characterize cellular and molecular immuno-
phenotypes in the general population and in disease cohorts (Netea et al. 
2016; Wang et al. 2018; Thomas et al. 2015)
These studies have opened up the possibility to evaluate and study the hu-
man immune system as a whole by simultaneously assessing the co-varia-
tion of its components (Zak, Tam, and Aderem 2014; Davis, Tato, and Furman 
2017; Delhalle et al. 2018; Brodin and Davis 2016). Given the nature of the 
immune system, a substantial proportion of its components can be found 
in circulation, thus blood samples can potentially give us an accurate repre-
sentation of the immune system from the general population (Netea et al. 
2016). The availability of this biological material has benefitted the study of 
immunogenomics, a combined field that studies genomics along with im-
mune cellular or molecular components in the general population. Immu-
nogenomic studies have shown us that the genetic component behind base-
line cell type composition has been thoroughly ascertained (Astle et al. 2016; 
Roederer et al. 2015; Orrù et al. 2013; Brodin et al. 2015). Nevertheless, to 
study a particular autoimmune disease, the characterization of the immune 
microenvironment surrounding lesions is necessary to uncover potential 
therapeutic strategies and autoimmunity drug targets (Gutierrez-Arcelus, 
Rich, and Raychaudhuri 2016; Davis 2008). On the other hand, if the objec-
tive is to characterize the genetic component of susceptibility to infectious 
diseases, then the inclusion parameters of the study design need to be con-
sidered. For example, volunteers who have already been diagnosed with 
autoimmune diseases, or who are immunocompromised, could already be 
susceptible to infectious diseases and inclusion of their data could confound 
the study, leading to spurious associations.
 
Deeper understanding of the inter-individual variations in our immune sys-
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tem response after encountering a pathogen would enable us to design bet-
ter vaccination strategies and treatments against infectious agents. Current-
ly, there are two common approaches to studying the variation of immune 
response among individuals. One is ex vivo stimulations that use subtypes 
of cells, or combinations of these, obtained from volunteers or patients. 
These cells are first isolated or propagated, then exposed to the same strain 
of a given pathogen under the exact same conditions (across individuals) 
(Netea et al. 2016; Li et al. 2016; Glinos, Soskic, and Trynka 2017; Duffy et al. 
2014). This strategy, although expensive, time-consuming and laborious, is 
currently the only one that allows us to dissect and compare the inter-indi-
vidual variation of the human immune response while also controlling for 
environmental exposure. Moreover, molecular immunophenotypes are the 
only ones that can currently be quantified using ex vivo stimulation, and it 
has been reported that the genetic influence over genetic molecular pheno-
types in immune cells can only be observed upon stimulated states (Glinos, 
Soskic, and Trynka 2017). The second approach used to study the response 
of the immune system in a given population is through the use of vaccina-
tions (Tsang et al. 2014; Zak, Tam, and Aderem 2014; Obermoser et al. 2013; 
Nakaya et al. 2011). Nevertheless, in this particular approach, a greater vari-
ation across responses is expected due to lifestyle differences. These differ-
ent strategies also differ in the biological questions they are able to answer. 
For instance, with vaccination cohorts, it is only possible to determine the re-
sponse effect of the adaptive branch of the immune system. In contrast, this 
is not a limitation for ex vivo stimulations, but one could argue that ex vivo 
stimulations do not possess the complete context of a host-like response. 
It is also the case that the amount of variation of most immunophenotypes 
across individuals is usually greater once it is quantified upon a certain stim-
uli, and this variation is dependent on which stimuli is used. 
Many cohort-bases studies have been established to study the influence of 
single nucleotide polymorphisms (SNPs) excerpt in human phenotypic vari-
ation and on complex phenotypes, both in the general population and for 
a plethora of diseases. The variation within the human immune composi-
tion and response has also been studied by employing deeply phenotyped 
population-based cohorts (Wijmenga and Zhernakova 2018). These popula-
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tion-based cohorts present a unique opportunity to perform unbiased re-
search considering the hypothesis-free strategy that is commonly used to 
investigate them. The greater the number of phenotypes that can be record-
ed from participants in a systematic way, the more complete a hypothesis 
can be when derived from the associations between genetics and pheno-
types. Methods to detect if SNPs are modulating a given phenotype depend 
on whether the phenotype is either discrete or quantitative. A discrete phe-
notype can take the form of any disease, therefore it can be categorized as a 
disease phenotype if its alleles are significantly enriched in disease patients, 
or as a healthy control if its alleles are significantly found in healthy controls. 
Using this approach, we are able to test millions of SNPs in genome-wide 
association studies (GWAS), where tens of thousands of SNPs have been 
associated with complex diseases, including autoimmune diseases and sus-
ceptibility to infectious diseases. In the event that the phenotype of interest 
is a quantitative trait, for instance a number of immune cells in circulation 
or the abundance a messenger RNA (mRNA) of a given gene, it is possible 
to calculate a quantitative trait loci (QTL). The QTL strategy assumes an ad-
ditive effect that is dose-dependent on a quantitative trait while taking into 
account the alleles that a person possesses in a SNP. These two approaches 
are the cornerstone of systems genomics, as they are used to link complex 
phenotypes to specific in from the genome through association. This makes 
it possible to identify regulatory networks that propagate genetic control and 
regulate complex phenotypes, including immune homeostasis, with the use 
of intermediate phenotypes, such as molecular or cellular measurements. 
Untangling these regulatory networks governing the immune system is one 
of the main goals behind the Human Functional Genomics Project (HFGP) 
(Netea et al. 2016). The HFGP and its population-based cohorts, for example 
the 200FG cohort, can serve as a basis for the design of immunogenomic 
reference cohorts (as shown in Figure 2) in which most of the immunophe-
noytpes are systematically ascertained, including ex vivo stimulations. As 
mentioned before, environmental cues driven by lifestyle and exposure ex-
plain the greater proportion of variation in the human immune composition 
(Brodin et al. 2015), which means a cohort study that aims to characterize 
the inter-individual variation of the immune system needs to properly ac-
count for this effect. Thus, comprehensive questionnaires should be filled 
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in by the participants to control for environmental and lifestyle differences. 
 
In the context of understanding and characterizing the inter-individual 
variation of the human immune response, a handful of cohort studies have 
tackled this question using a variety of approaches. In this thesis, several 
population-based cohort studies were used to characterize immune system 
composition and response, and these are described in detail in Box 1. Nev-
ertheless, other cohorts such as the UKBiobank (Sudlow et al. 2015) have ex-
tensively dissected the genetic component of blood traits, such as cell counts 
of major immune cell types, and its implications in autoimmune diseases 
General introduction and aim and outline of thesis.
Figure 2. Schematic of an immunogenomic population-based reference cohort. The dif-
ferent layers of phenotypic information can then be used to link the genetic and environmen-
tal cues to an adequate immune response, shedding light to the inter-individual variation of 
the immune response. 
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(Astle et al. 2016). This thesis followed a similar approach however, it quan-
tifies a greater and more diverse set of cell subtypes in a smaller number of 
participants. In a more specialized fashion, the Milieu Interior (Thomas et 
al. 2015) project aimed to establish a reference of the human immune vari-
ation using 1,000 participants who had been deeply immune-phenotyped, 
including the collection of molecular phenotypes upon ex vivo stimulations. 
Such ex vivo stimulations are comparable to the ones applied in the 500FG 
cohort. We made use of the molecular phenotypes upon stimulation in the 
500FG cohort to detect and characterize the genetic component of the im-
mune response by mapping cytokine QTLs. We then integrated all available 
omic datasets to interrogate whether cytokine production can be predict-
ed. A limitation of population-wide cohorts is that they do not include the 
characterization of tissue-specific immune cell populations, which we know 
contribute to the physiopathology of several autoimmune diseases and 
could potentially reveal novel gene drivers and/or potential therapy targets. 
To tackle the problem of the missing context derived from the cell type–
tissue information in general population cohorts, we developed Decon2, a 
statistical framework to predict the proportions of subpopulations within a 
bulk tissue (in this case whole blood). We make use of these predicted cell 
subpopulations to interrogate the genetic effect on gene expression in the 
context of each cell subpopulation. Furthermore, we show how character-
izing the transcriptional and epigenetic response to stimulation by single 
cytokines can potentially help us identify pathways involved in the cellular 
de-regulation. It is also worth mentioning, as the academic and research 
community develops larger and more comprehensive immunogenomic co-
horts, that collaborative efforts to combine these cohorts are needed to ex-
plore the variation of the human immune system and its response across 
populations, environmental exposures and diseases. 
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Box 1. Cohorts used in the studies reported in this thesis.
Human Functional Genomics Project (HFGP): 
 The HFGP is an umbrella project comprising multiple popula-
tion-based cohorts of adults of western European descent that 
was started in the second half of 2013 by Radboud University 
Medical Center, the University Medical Center Groningen and the 
Broad institute. The main objective of the HFGP is to character-
ize and understand the inter-individual variation in the human 
immune system composition and response by integrating mul-
tiple omics-like technologies with deep immune-phenotyping in 
healthy volunteers and disease cohorts. 
200 Functional Genomics (200FG): 
 The 200FG cohort is the first project conducted by the HFGP. It 
consists of 200 adult individuals of Dutch descent. The 200FG co-
hort aimed to characterize the human cytokine responses to ex 
vivo stimulations of bacterial and fungal pathogens in PBMCs. It 
did so by exploring the contribution of common genetic variation 
to the production of cytokines upon ex vivo stimulation.
500 Functional Genomics (500FG): 
Similar to the 200FG cohort, 500FG consists of ~500 adult indi-
viduals of Dutch descent. Its main objective was to characterize 
the inter-individual variation of the human immune response. 
500FG builds upon the functional immune phenotyping gener-
ated in 200FG by increasing the number of pathogens, cell types 
and cytokines that were measured in the ex vivo stimulations. 
Additionally, for the 500FG cohort, an extensive quantification of 
the circulating immune cell composition was obtained by FACS 
with keen interest in the adaptive compartment (B and T cell sub-
populations). On top of these immune traits, other molecular and 
cellular phenotypes were profiled, such as the circulating metab-
General introduction and aim and outline of thesis.
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olome and microbiome composition. 
LifeLines Deep (LLDeep): 
 The LLDeep cohort is a subset of the LifeLines cohort, the largest 
longitudinal cohort from the Netherlands. LLDeep was conceived 
with the aim of studying the functional genomics of the general 
population. It consists of 1,500 individuals for whom extensive 
multi-omic molecular phenotypes were collected from blood, in-
cluding RNA-Seq–based gene expression, methylation, metabo-
lomics as well as stool metabolomics and microbiome composi-
tion from stool. All these molecular phenotypes are in addition to 
the 2,000 phenotypes assessed by the LifeLines cohort.  
The biobank based integrative omics study (BIOS): 
BIOS’s principal aim is to generate a platform for researchers 
who work on integrative omics studies in the Netherlands. It 
encompasses data from ~4,000 individuals from six Dutch bio-
banks. For each of these individuals, genetics (imputed genotype 
arrays), methylome (450k array), transcriptome (RNA-Seq based) 
and phenotypic information have been harmonized. 
21
Aim and Outline of the thesis 
The overall aim of this thesis was to further understand the inter-individual 
variation of the human immune response and the role of the transcriptome 
in immune function. We did this by developing and applying computational 
and statistical approaches that aimed to integrate multiple layers of biolog-
ical information. This doctoral thesis contains two main sections that are 
driven by different objectives. 
In Section 1 (chapters 2-4) the main objective was to understand the in-
ter-individual variation of the human immune system by characterizing the 
impacts of common genetic variation, host status and environment on the 
immune composition and response by the use of deeply phenotyped popu-
lation-based cohorts. 
In Section 2 (chapters 5-7) we aimed to dissect the role of the transcrip-
tome in immune cell types, first by developing and presenting a method to 
characterize the impact of common genetic variation in gene expression on 
immune cell subpopulations within bulk mixtures of cells, and second by in-
tegrating transcriptome and epigenomic measurements in disease-relevant 
immune cell subpopulations. 
Section 1 
In Chapter 2, a systems immunology approach was used to comprehen-
sively determine the impact of environmental factors, host phenotypes and 
common genetic variation on the composition of the immune cell reper-
toire in peripheral blood, including associations with immunoglobulin levels, 
from ~500 healthy volunteers from the 500FG cohort. Here we found that 
environmental cues play a major role in defining the abundance of circu-
lating B cells, whereas the T cell subpopulations have a significantly bigger 
genetic component.  
Chapter 3 describes a systems genomics study aimed at characterizing the 
General introduction and aim and outline of thesis.
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genetic component behind the immune response. This was done by charac-
terizing the variants that affect the production of cytokines in multiple cell 
types upon ex vivo simulations with different pathogens and immunological 
ligands. We found that host genetics plays a major role in the variability of 
the immune response. Variants associated to the production of cytokines 
upon stimulation are located close by genes essential for pathogen recog-
nition (the TLR locus), cytokine signaling and complement inhibitors. The 
variants associated to monocyte-specific cytokines are enriched for regions 
under positive evolutionary selection and for variants previously associated 
to infectious diseases. 
In Chapter 4 we present a comprehensive characterization of associations 
between host factors, including baseline immune phenotypes and molec-
ular profiles (gene expression, circulating metabolomics and microbiome 
composition), and cytokine production upon ex vivo stimulations. By group-
ing up to 11 categories of host factors, we could explain up to 67% of the 
inter-individual variation in cytokine production upon stimulation. By apply-
ing genetics alone, we were able to accurately predict cytokine levels upon 
simulation for some cytokines (correlation coefficient predicted vs observed 
ranging from 0.28 to 0.89). 
Section 2
In Chapter 5 we developed and presented a novel statistical framework for 
deconvoluting bulk blood tissue expression quantitative trait loci (eQTLs) 
into immune cell type eQTLs. We propose a two-step approach in which we 
first develop a method that use the gene-expression of whole blood to pre-
dict the proportions of immune cell subpopulations (Decon-cell). Next, we 
integrated the genotype data, gene expression levels and predicted propor-
tions of immune cell types into a linear model where we dissect bulk gene 
expression into its cell-type proportions and evaluate whether there is a sig-
nificant effect of the genotype on the gene expression on a particular cell 
type (Decon-eQTL). We then extensively validated the two steps of our pro-
posed framework. For Decon-cell, we validated our prediction using multiple 
independent cohorts and transcriptional profiles from purified immune cell 
23
subpopulations. For Decon-eQTL, we made use of eQTL datasets from puri-
fied cell subpopulations. Using this approach we set a new standard for the 
detection of cell-type eQTLs using bulk-tissue expression data. 
In Chapter 6 we make use of patient derived intra-epithelial cytotoxic lym-
phocytes (IE-CTLs) to study and dynamically characterize the transcriptomic 
and epigenetic changes upon exposure to tissue-derived (IFN and IL-15) and 
adaptive cytokines (IL-21). These cytokines are known to be upregulated in 
several tissue-specific autoimmune diseases, including celiac disease, type 
1 diabetes and inflammatory bowel disease. We show that tissue-derived 
cytokines induce massive and distinct temporal changes, and that a core 
set of immune genes are being similarly up-regulated by all three cytokines 
and show enrichment for genes located near genetic risk factors for autoim-
mune-mediated diseases.  
Finally, in Chapter 7, we discuss the findings reported in this thesis in a 
broader context and postulate the possible future directions of the fields of 
systems immunology and systems genomics.
General introduction and aim and outline of thesis.
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